Insulet
Diabetes: The Path To An Artificial Pancreas Looks A Little More Reasonable
There are more than a few similarities between the idea of building an artificial pancreas and finding the Holy Grail – everybody agrees that it would be great if it were possible, but it’s definitely not easy, and more than a few people think it’s a vain pursuit. To that end, while there was once again a fair bit of attention at the 73rd annual ADA meeting last week and some encouraging incremental study data, the road to success is still a long and uncertain one.
Diabetes: Wall Street cheers Insulet’s spike in sales, narrowed losses
The strange case of the diabetes market
Diabetes: Insulet and Eli Lilly team up for specialty insulin pump
Diabetes: Insulet gains on strong Q4, lands FDA win
Holaira raises $10M for lung device | Wall Street Beat
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira’s existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.
Diabetes: Insulet and Dexcom call it quits on development agreement
Urologix names new CEO | Personnel Moves
MassDevice.com +3 | The top 3 med-tech stories for Jan. 14, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.